Molecular Model of Imatinib

Credit: Scimat/SCIENCE PHOTO LIBRARY

Caption: Molecular model of Imatinib (C29 H31 N7 O). Imatinib is part of a new class of drugs used in the treatment of chronic myelogenous leukaemia (CML), gastrointestinal stromal tumours (GIST) and a number of other malignancies. It acts by specifically inhibiting an enzyme (a receptor tyrosine kinase) that is characteristic of a particular cancer cell, rather than non-specifically inhibiting and killing all rapidly dividing cells. Carbon in grey; Hydrogen in yellow; Nitrogen in blue; Oxygen in red. Mol. mass: 493.603 g/mol.

Release details: Model release not required. Property release not required.

Keywords: c29 h31 n7 o, cancer treatment, carbon, chemistry, cml treatment, drugs, gastrointestinal stromal, gist, gleevec, glivec, hydrogen, imatinib, malignancies, malignancy, medicines, model, modelling, molecular, molecular structure, molecules, myelogenous leukaemia treatment, nitrogen, oxygen, tumours, tyrosine kinase, tyrosine-kinase inhibitor

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.